Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IBRX News
ImmunityBio Reports 168% Revenue Growth in Q1 2026
3d ago
Newsfilter
ImmunityBio's Anktiva Application Decision Approaches
3d ago
stocktwits
ImmunityBio Shareholder Class Action Reminder
2d ago
Globenewswire
ImmunityBio Faces Securities Fraud Class Action Lawsuit
2d ago
PRnewswire
ImmunityBio Faces Class Action Lawsuit for Securities Violations
2d ago
Globenewswire
ImmunityBio Faces Securities Class Action Lawsuit
2d ago
Globenewswire
ImmunityBio Faces Class Action Lawsuit
2d ago
PRnewswire
ImmunityBio Reports Q1 Loss but Strong Anktiva Demand Persists
2d ago
stocktwits
Multiple Companies Face Class Action Lawsuits
3d ago
Globenewswire
ImmunityBio Securities Class Action Reminder
3d ago
Globenewswire
ImmunityBio Faces Securities Fraud Class Action Lawsuit
3d ago
Globenewswire
Multiple Companies Face Class Action Lawsuits
3d ago
Globenewswire
ImmunityBio Reports 168% Sales Growth in Q1 Despite Wider Loss
3d ago
stocktwits
ImmunityBio Class Action Lead Plaintiff Deadline Approaches
3d ago
Newsfilter
ImmunityBio Reports Strong Q1 Revenue Growth Despite EPS Miss
3d ago
seekingalpha
ImmunityBio Securities Class Action Reminder
3d ago
Globenewswire
Show More News
